🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Radiation in combination with Provenge based immunotherapy may improve outc...
Status
Completed
Location
21st Century Oncology
Start Date
2014-06
Trial ID
NCT02232230
Treatments Being Tested
This is a randomized, open-label study designed to assess the effects of si...
Status
Completed
Location
Urological Associates of Southern Arizona, P.C.
Start Date
2013-09
Trial ID
NCT01981122
Treatments Being Tested
In this i-SABR (immunotherapy + Stereotactic Ablative Body Radiation) trial...
Status
Completed
Location
University of Texas Southwestern Medical Center
Start Date
2013-07-10
Trial ID
NCT01818986
Treatments Being Tested
The purpose of this study is to further quantify the risk of cerebrovascula...
Status
Completed
Location
Birmingham Hematology and Oncology Associates, LLC
Start Date
2011-01-27
Trial ID
NCT01306890
Treatments Being Tested
This study aims to evaluate patients with metastatic castrate-resistant pro...
Status
Completed
Location
Duke University Medical Center
Start Date
2014-03
Trial ID
NCT02036918
Treatments Being Tested
This is a randomized, double blind, placebo controlled trial of immunothera...
Status
Completed
Location
Multiple Locations
Start Date
2000-05
Trial ID
NCT01133704
Treatments Being Tested
This is a randomized, double blind, multi-institutional phase II therapeuti...
Status
Completed
Location
University of Illinois Medical Center
Start Date
2012-10-01
Trial ID
NCT01560923
Treatments Being Tested
This randomized phase II trial studies how well giving sipuleucel-T with or...
Status
Completed
Location
City of Hope Medical Center
Start Date
2013-06-07
Trial ID
NCT01807065
Treatments Being Tested
Proposed immunotherapy with an extended course of Sipuleucel-T treatment ma...
Status
Active Not Recruiting
Location
University of Oklahoma Health Sciences Center, Stephenson Cancer Center
Start Date
2023-11-12
Trial ID
NCT05806814
Treatments Being Tested
Provenge is an investigational product designed to activate a man's own ant...
Status
Completed
Location
South Orange County Urological
Start Date
2003-07
Trial ID
NCT00065442
Treatments Being Tested